“…Stable transfectants of the CHO cell variant TRVb-1 expressing Tac chimeric proteins TGG and TTF (Ghosh et al, 1998;Mallet and Maxfield, 1999) (Prescott et al, 1997); sheep anti-TGN46, Serotec, Oxford, UK)]; cation-independent mannose 6-phosphate receptor (mAb αMPR300, Affinity BioReagents, Golden, CO); Tac (Santini et al, 1998); golgin-97 (rb αgolgin-97 and mAb αgolgin-97, E. K. L. Chan, Scripps Res. Inst., La Jolla, CA); giantin (Linstedt and Hauri, 1993); Rab6 (C-19 rb αRab6, Santa Cruz Biotechnology, Santa Cruz, CA); ERGIC-53 (Schweizer et al, 1988); mannosidase II (Moremen and Touster, 1985); galactosyltransferase (Berger and Hesford, 1985); MG160 (Gonatas et al, 1989); AP-1 (Ahle et al, 1988); Lamp1 (Carlsson et al, 1988;Mane et al, 1989); Lamp2 (Mane et al, 1989); CD63 (mAb αCD63, Beckman Coulter, Fullerton, CA); transferrin receptor (mAb B3/25, Roche Molecular Biochemicals); T7 epitope (mAb from Novagen, Madison, WI). mAbs to EEA1, human tGolgin-1 (p230), GM130, p115 and syntaxin 6 were from Becton Dickenson/ Transduction Laboratories (San Diego, CA).…”